Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Drug interaction study for IPF patients taking multiple medications

NCT ID NCT06241560

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 35 times

Summary

This study looks at how pirfenidone changes the amount of another medicine, BI 1015550, in the blood of adults with idiopathic pulmonary fibrosis (IPF). Twenty participants aged 40 and older will take both drugs over about a month, with frequent blood tests and clinic visits. The goal is to understand how these medicines interact, not to treat the disease directly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • LTD "Aversi clinic"

    RECRUITING

    Tbilisi, 160, Georgia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • LTD The First Medical Center

    RECRUITING

    Tbilisi, 0180, Georgia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Renovatio Clinical-The Woodlands-69551

    RECRUITING

    The Woodlands, Texas, 77380, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.